|
1
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
Executive summary: Heart disease and stroke statistics-2014 update:
A report from the American Heart Association. Circulation.
129:399–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman
M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C,
et al: Heart disease and stroke statistics-2017 Update: A Report
From the American Heart Association. Circulation. 135:e146–e603.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Meara E, Thibodeau-Jarry N, Ducharme A
and Rouleau JL: The epidemic of heart failure: A lucid approach to
stemming the rising tide. Can J Cardiol. 30 12 Suppl:S442–S454.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al:
Executive summary: Heart disease and stroke statistics-2013 update:
A report from the American Heart Association. Circulation.
127:143–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barquera S, Pedroza-Tobías A, Medina C,
Hernández-Barrera L, Bibbins-Domingo K, Lozano R and Moran AE:
Global overview of the epidemiology of atherosclerotic
cardiovascular disease. Arch Med Res. 46:328–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma H, Guo R, Yu L, Zhang Y and Ren J:
Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial
ischaemia/reperfusion injury: Role of autophagy paradox and toxic
aldehyde. Eur Heart J. 32:1025–1038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CH, Budas GR, Churchill EN, Disatnik
MH, Hurley TD and Mochly-Rosen D: Activation of aldehyde
dehydrogenase-2 reduces ischemic damage to the heart. Science.
321:1493–1495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Doser TA, Turdi S, Thomas DP, Epstein PN,
Li SY and Ren J: Transgenic overexpression of aldehyde
dehydrogenase-2 rescues chronic alcohol intake-induced myocardial
hypertrophy and contractile dysfunction. Circulation.
119:1941–1949. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aldi S, Takano K, Tomita K, Koda K, Chan
NY, Marino A, Salazar-Rodriguez M, Thurmond RL and Levi R:
Histamine H4-receptors inhibit mast cell renin release in
ischemia/reperfusion via protein kinase C ε-dependent aldehyde
dehydrogenase type-2 activation. J Pharmacol Exp Ther. 349:508–517.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gomes KM, Campos JC, Bechara LR, Queliconi
B, Lima VM, Disatnik MH, Magno P, Chen CH, Brum PC, Kowaltowski AJ,
et al: Aldehyde dehydrogenase 2 activation in heart failure
restores mitochondrial function and improves ventricular function
and remodelling. Cardiovasc Res. 103:498–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liao J, Sun A, Xie Y, Isse T, Kawamoto T,
Zou Y and Ge J: Aldehyde dehydrogenase-2 deficiency aggravates
cardiac dysfunction elicited by endoplasmic reticulum stress
induction. Mol Med. 18:785–793. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Koda K, Salazar-Rodriguez M, Corti F, Chan
NY, Estephan R, Silver RB, Mochly-Rosen D and Levi R: Aldehyde
dehydrogenase activation prevents reperfusion arrhythmias by
inhibiting local renin release from cardiac mast cells.
Circulation. 122:771–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gomes KM, Bechara LR, Lima VM, Ribeiro MA,
Campos JC, Dourado PM, Kowaltowski AJ, Mochly-Rosen D and Ferreira
JC: Aldehydic load and aldehyde dehydrogenase 2 profile during the
progression of post-myocardial infarction cardiomyopathy: Benefits
of Alda-1. Int J Cardiol. 179:129–138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun L, Ferreira JC and Mochly-Rosen D:
ALDH2 activator inhibits increased myocardial infarction injury by
nitroglycerin tolerance. Sci Transl Med. 3:107ra1112011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Perez-Miller S, Younus H, Vanam R, Chen
CH, Mochly-Rosen D and Hurley TD: Alda-1 is an agonist and chemical
chaperone for the common human aldehyde dehydrogenase 2 variant.
Nat Struct Mol Biol. 17:159–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bozkurt B, Torre-Amione G, Warren MS,
Whitmore J, Soran OZ, Feldman AM and Mann DL: Results of targeted
anti-tumor necrosis factor therapy with etanercept (ENBREL) in
patients with advanced heart failure. Circulation. 103:1044–1047.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mann DL, McMurray JJ, Packer M, Swedberg
K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, et
al: Targeted anticytokine therapy in patients with chronic heart
failure: Results of the Randomized Etanercept Worldwide Evaluation
(RENEWAL). Circulation. 109:1594–1602. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blasi ER, Heyen J, Hemkens M, McHarg A,
Ecelbarger CM and Tiwari S: Effects of chronic PPAR-agonist
treatment on cardiac structure and function, blood pressure, and
kidney in healthy sprague-dawley rats. PPAR Res. 2009:2378652009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Whitbeck MG, Charnigo RJ, Khairy P, Ziada
K, Bailey AL, Zegarra MM, Shah J, Morales G, Macaulay T, Sorrell
VL, et al: Increased mortality among patients taking
digoxin-analysis from the AFFIRM study. Eur Heart J. 34:1481–1488.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou YC, Liu B, Li YJ, Jing LL, Wen G,
Tang J, Xu X, Lv ZP and Sun XG: Effects of buyang huanwu decoction
on ventricular remodeling and differential protein profile in a rat
model of myocardial infarction. Evid Based Complement Alternat Med.
2012:3852472012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pitarys CJ II, Virmani R, Vildibill HD Jr,
Jackson EK and Forman MB: Reduction of myocardial reperfusion
injury by intravenous adenosine administered during the early
reperfusion period. Circulation. 83:237–247. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu B, Zhang J, Liu W, Liu N, Fu X, Kwan H
and Liu S, Liu B, Zhang S, Yu Z and Liu S: Calycosin inhibits
oxidative stress-induced cardiomyocyte apoptosis via activating
estrogen receptor-α/β. Bioorg Med Chem Lett. 26:181–185. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai HB, Sun XG, Liu ZF, Liu YW, Tang J,
Liu Q, Ji BM, Song YH, Zhou YC, Yang MH and Lv ZP: Effects of
dahuangzhechong pills on cytokines and mitogen activated protein
kinase activation in rats with hepatic fibrosis. J Ethnopharmacol.
132:157–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tham YK, Bernardo BC, Ooi JY, Weeks KL and
McMullen JR: Pathophysiology of cardiac hypertrophy and heart
failure: Signaling pathways and novel therapeutic targets. Arch
Toxicol. 89:1401–1438. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jain M, Liao R, Ngoy S, Whittaker P,
Apstein CS and Eberli FR: Angiotensin II receptor blockade
attenuates the deleterious effects of exercise training on post-MI
ventricular remodelling in rats. Cardiovasc Res. 46:66–72. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Y and Weber KT: Infarct scar: A
dynamic tissue. Cardiovasc Res. 46:250–256. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Yang H, Song L, Li N, Han QY, Tian
C, Gao E, Du J, Xia YL and Li HH: AGGF1 protects from myocardial
ischemia/reperfusion injury by regulating myocardial apoptosis and
angiogenesis. Apoptosis. 19:1254–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takemura G and Fujiwara H: Role of
apoptosis in remodeling after myocardial infarction. Pharmacol
Ther. 104:1–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mill JG, Stefanon I, dos Santos L and
Baldo MP: Remodeling in the ischemic heart: The stepwise
progression for heart failure. Braz J Med Biol Res. 44:890–898.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doorn JA, Hurley TD and Petersen DR:
Inhibition of human mitochondrial aldehyde dehydrogenase by
4-hydroxynon-2-enal and 4-oxonon-2-enal. Chem Res Toxicol.
19:102–110. 2006. View Article : Google Scholar : PubMed/NCBI
|
